IP Library Granted Patent US 9,737,388
Granted Patent B2
US 9,737,388 · App. 14/807,382 · Granted Aug 22, 2017

Implants, tools, and methods for treatment of pelvic conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,737,388
App. No.
14/807,382
Granted
Aug 22, 2017
Kind
B2
Abstract

Described are various embodiments of surgical procedures, systems, implants, devices, tools, and methods, useful for treating pelvic conditions in a male or female, the pelvic conditions including incontinence (various forms such as fecal incontinence, stress urinary incontinence, urge incontinence, mixed incontinence, etc.), vaginal prolapse (including various forms such as enterocele, cystocele, rectocele, apical or vault prolapse, uterine descent, etc.), and other conditions caused by muscle and ligament weakness, the devices and tools including devices and tools for anchoring an implant to supportive tissue and adjusting the implant.

Claims (24)

1. A method of treating fecal incontinence, the method comprising

providing a pelvic implant comprising

a tissue support portion, a first extension portion, and a second extension portion, and

a self-fixating tip at an end of each extension portion,

providing a suture separate from the implant,

placing the implant in a patient to support tissue selected from an anus, anal sphincter, and rectum,

after placing the implant, placing a portion of a length of the suture through the first extension portion at two locations, each location being located between a medial end of the first extension portion and a distal end of the first extension portion, the suture being passed through the first extension portion to form at least one loop in the first extension portion such that pulling an end of the suture causes a length of the first extension portion to decrease, and

adjusting the length of the first extension portion by pulling the suture.

2. A method as recited at claim 1 comprising providing a second suture comprising a length and a loose end, and placing a portion of the length of the second suture through the second extension portion, at two locations, each location being located between a medial end of the second extension portion and a distal end of the second extension portion, the second suture being passed through the second extension portion to form at least one loop in the second extension portion such that pulling the loose end of the second suture causes a length of the second extension portion to decrease, and adjusting the length of second extension portion by pulling the loose end of the second suture.

3. A method as recited at claim 2 comprising adjusting the length of the first extension portion and the length of the second extension portion together to prevent the supported tissue from being moved in a left or a right direction within the patient.

4. A method as recited at claim 1 comprising:

creating a medial incision in the patient,

placing the tissue support portion to contact tissue to support the anus,

placing the distal end of the first extension portion in a tissue path extending toward a first obturator foramen of the patient, and

placing the distal end of the second extension portion in a tissue path extending toward a second obturator foramen of the patient.

5. A method as recited at claim 1 , comprising creating a medial incision in a pathway selected from a transvaginal, suprapubic, and perineal floor.

6. A method as recited at claim 1 , comprising providing a suture passer capable of passing the suture through the first extension portion.

7. A method as recited at claim 6 comprising using the suture passer to intraoperatively place the suture through the first extension portion.

8. A method as recited as claim 6 , wherein the suture passer comprises a proximal and distal end, the distal end comprising a first and a second opposing jaws capable of passing intraoperatively through a surgical incision.

9. A method as recited at claim 6 , wherein passing the suture through the first extension portion creates a desired reduction in length of the implant.

10. A method as recited at claim 6 , wherein the suture passer is capable of passing the suture more than one time through the first extension portion.

11. A method as recited at claim 6 , wherein the suture passer comprises a proximal and distal end, the distal end comprising a mesh cincher capable of grasping the implant and a first and a second opposing jaws capable of passing the suture through the first extension portion.

12. A method as recited at claim 1 , comprising creating a tissue path from a medial incision to a region selected from a bulbospongiosus muscle, an obturator foramen, or a rectus fascia tissue.

13. A method as recited at claim 1 , comprising creating a tissue path from a medial incision through an obturator foramen and around a pubic ramus bone.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043777/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043778/0167 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →